General Fusion and University of Lisbon Collaborate on State-of-the-Art Diagnostic for LM26 Plasma Injector 12-12-2023, 21:00

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed 21-09-2025, 09:15

The Southport CoLAB & The Southport School Announce 9-03-2023, 22:23